Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

GABAPENTIN ENACARBIL vs GADOBENATE DIMEGLUMINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

GABAPENTIN ENACARBIL vs GADOBENATE DIMEGLUMINE: Safety Overview

Metric GABAPENTIN ENACARBIL GADOBENATE DIMEGLUMINE
Total FAERS Reports 1,833 1,965
Deaths Reported 649 50
Death Rate 35.4% 2.5%
Hospitalizations 237 330
Average Patient Age 54.6 yrs 52.8 yrs
% Female Patients 61.5% 62.8%
FDA Approval Date Apr 6, 2011 Nov 23, 2004
Manufacturer Azurity Pharmaceuticals, Inc. (former... BRACCO DIAGNOSTICS INC
Route ORAL INTRAVENOUS
Marketing Status Prescription Prescription